Mike D. Burns
Directeur/Bestuurslid bij CureLab Oncology, Inc.
Profiel
Mike D.
Burns is currently an Independent Director at CureLab Oncology, Inc. He previously held positions as a Managing Director at TL Ventures, Inc., a Director at Texas Instruments Lehigh Valley, Inc., and a Director-Business Development at Agere, Inc. From 2011 to 2020, he served as the Managing Partner at Alara Capital LLC.
Mr. Burns obtained his undergraduate degree from the University of Pennsylvania, his graduate degree from Moore College of Art & Design, and another undergraduate degree from The Wharton School of the University of Pennsylvania.
Actieve functies van Mike D. Burns
| Bedrijven | Functie | Begin |
|---|---|---|
CureLab Oncology, Inc.
 CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mike D. Burns
| Bedrijven | Functie | Einde |
|---|---|---|
Alara Capital LLC
 Alara Capital LLC Investment ManagersFinance Alara Capital LLC (Alara Capital) is a venture capital/private equity firm founded in 2005. The firm is headquartered in Austin, Texas. | Private Equity Investor | 01-01-2020 |
| Agere, Inc. | Corporate Officer/Principal | - |
Texas Instruments Lehigh Valley, Inc.
 Texas Instruments Lehigh Valley, Inc. SemiconductorsElectronic Technology Texas Instruments Lehigh Valley, Inc. designs and develops radio frequency power semiconductor solutions. The company was founded by Mark E. Granahan in 2004 and is headquartered in Bethlehem, PA. | Directeur/Bestuurslid | - |
TL Ventures, Inc.
 TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Private Equity Investor | - |
Opleiding van Mike D. Burns
| University of Pennsylvania | Undergraduate Degree |
| Moore College of Art & Design | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Alara Capital LLC
Alara Capital LLC Investment ManagersFinance Alara Capital LLC (Alara Capital) is a venture capital/private equity firm founded in 2005. The firm is headquartered in Austin, Texas. | Finance |
Texas Instruments Lehigh Valley, Inc.
Texas Instruments Lehigh Valley, Inc. SemiconductorsElectronic Technology Texas Instruments Lehigh Valley, Inc. designs and develops radio frequency power semiconductor solutions. The company was founded by Mark E. Granahan in 2004 and is headquartered in Bethlehem, PA. | Electronic Technology |
| Agere, Inc. | Industrial Services |
CureLab Oncology, Inc.
CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
